) (3.45%) Other income 23.06 29.83 6.77 29.34% Selling and administrative expenses 195.24 200.68 5.44 2.79% Operating profit 993.74 954.83 (38.91) (3.92%) Finance cost 56.66 70.71 14.06 24.81% Income tax

(which is the highest transaction size in accordance with Operating Profit Criteria) and when taken into account other acquisition of assets by the Company during the past 6 months, the aggregate

4,061 million, increased by Baht 702 million or 21% from 2018 mainly caused from the recognition of the operating results of the projects that the Company has invested and the commencement of commercial

Company Limited and its subsidiaries (“the Company”) would like to clarify herewith the operating result for the year 2018 as follows:- Financial Position As at 31 December 2018, total consolidated assets

. DOD2019/004 February 20, 2019 Subject: Management’s discussion and analysis of the Company’s operating results for the year 2018 period To: President The Stock Exchange of Thailand DOD Biotech Public

RP-AC 001/2019 February 26, 2019 Subject Clarification of 2018 Operating Results To Directors and Managers of the Stock Exchange of Thailand Richy Place 2002 Public Company Limited (RICHY) would like

November 12, 2004 1/3 No: SN. 036/2017 May 11, 2017 Subject: Clarification of Operating Results and Financial Status the six-month period ended March 31, 2017 Attention: President The Stock Exchange

Justification_E_1-61 NO. AC. 002/2018 15 May 2018 Subject: Clarification of changes in operating performance of more than 20% To: The President of the Stock Exchange of Thailand M. K. Real Estate

operating results that posted a difference greater than 20% from the preceding year To: Director and Manager the Stocks Exchange of Thailand World corporation public company limited ("the Company") and its

/2561 November 12, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q3/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited